INTRODUCTION
Previous studies showed that obese subjects are more susceptible to cardiovascular disease, hypertension, cerebrovascular disease, and diabetes mellitus than are nonobese subjects (1). They have a higher incidence of infection and some types of cancer (2, 3) , suggesting impaired immune function. In humans, only a few studies have directly compared specific immune responses in obese and nonobese subjects. It is known that obesity induces decreases in both T lymphocyte response to concanavalin A (conA) and B lymphocyte response to pokeweed mitogen (4) . In addition, a negative correlation between percentage body fat and natural killer cell activity was found in both elderly women (5) and adult men (6) . Elderly people (> 60 y of age) are also at risk from an increased incidence of infection. Their peripheral blood lymphocytes show an impaired proliferative capacity and a decreased reactivity to mitogens (7) . We found and reported that obesity suppresses lymphocyte functions, natural killer cell activity, and lymphocyte mitogenesis in men and women > 60 y of age (8) . This suggests that obesity is a risk factor for deteriorating cellular immune functions. However, the mechanism by which obesity decreases cellular immune functions remains to be elucidated.
Because Meydani et al (9) reported that decreased cellular immunity in elderly people was associated with increased production of prostaglandin E 2 (PGE 2 ), the decrease of cellular immunity in obese elderly subjects may be induced by increased production of PGE 2 . We found that glucose is the main energy source for lymphocytes at the stage of proliferation (10) . Decreased proliferation of peripheral blood lymphocytes in obese subjects may be related to impairment of glucose uptake by lymphocytes. It is known that glucose transport into cells is performed by glucose transporter (GLUT) expressed on their membranes (11) . In particular, GLUT-1 is expressed on lymphocyte membranes and transports glucose into lymphocytes after mitogen stimulation. Obesity may modulate the expression of GLUT-1 in lymphocytes. Mitogen response is initiated by the binding of mitogen to mitogen receptors. Because T cell mitogens such as phytohemagglutinin and concanavalin A (conA) are present in sufficient amounts under in vitro incubation with splenic lymphocytes, a decreased mitogen response in obese subjects may be due to decreased expression of mitogen receptors on their lymphocytes.
Zucker rats increase their body weights by overfeeding, which induces hyperlipidemia and hypercholesteremia (12) . Although plasma insulin concentrations are several times higher in obese than in lean Zucker rats, plasma glucose concentrations are simDecreased mitogen response of splenic lymphocytes in obese Zucker rats is associated with the decreased expression of glucose transporter 1 (GLUT-1) ilar (13) . These observations suggest that although obese Zucker rats are not frankly diabetic, they are insulin resistant.
Therefore, we designed the present studies using Zucker rats as a model for obesity to investigate, first, whether a decreased mitogen response in obese rats is associated with increased production of PGE 2 , second, whether decreased mitogen response in obese subjects is related to an impairment of glucose transport in lymphocytes and, third, whether obesity induces decreased expression of mitogen receptors on lymphocytes.
MATERIALS AND METHODS

Animals and diet
Zucker rats were originally obtained from Kiwa Experimental Animal Co, Ltd (Wakayama, Japan) and were propagated in our laboratory. In this experiment, 12-mo-old female Zucker rats were used. They were fed a nonpurified diet (MF; Oriental Yeast Co, Ltd, Tokyo) after weaning. At 8 wk of age they were divided into groups of 10 lean (Fa/?) and obese (fa/fa) rats. Until the end of the experiment (12 mo of age), all rats had free access to food and drinking water and were housed in a rodent facility at 22 ± 1°C with a 12-h light-dark cycle. Body weight and food intake were measured daily. The study was conducted in accord with the Helsinki Declaration of 1975 as revised in 1983.
Blood collection and measurements of plasma glucose, insulin, and triacylglycerol
Blood was drawn from the inferior vena cava of each rat into syringes with heparin at the end of the experiment just before the animals were killed. Plasma obtained by centrifugation at 600 ϫ g for 20 min at 4°C was stored in aliquots at Ϫ40°C until glucose, insulin, and triacylglycerol concentrations were determined. Concentrations of glucose, insulin, and triacylglycerol in plasma were measured by using a Glucose B-Wako test kit (Wako Pure Chemical Industries, Ltd, Osaka, Japan), a double-antibody radioimmunoassay (Pharmacia, Uppsala, Sweden), and a Triglyceride E-Wako test kit (Wako Pure Chemical Industries), respectively.
Preparation and mitogenesis of splenocytes
Rats were anesthetized with sodium pentobarbital (1 L/g body wt) and exsanguinated by cutting off the arteries of both kidneys. The spleen was aseptically excised, weighed, and minced with scissors. The splenocytes were dissociated by using a stainless steel screen and adjusted to 1 ϫ Twenty-four hours later, the cells were harvested onto a glass fiber filter with an automated sample harvester (Mash II Harvester; Flow Laboratories, Rockville, MD). Their radioactivity was measured by using a liquid scintillation spectrometer after the filters had been kept overnight at room temperature.
Prostaglandin E 2 production by splenocytes
Splenocytes (1 ϫ 10 9 cells/L) were incubated with conA (5 mg/L) in a 5%-CO 2 incubator at 37°C for 48 h. Then the supernates of the splenocyte cultures were harvested and used for PGE 2 analysis. PGE 2 concentration in the supernate was determined by using the prostaglandin E 2 enzyme immunoassay system (Amersham International plc, Amersham, United Kingdom).
In vitro treatment with indomethacin
The effect of indomethacin on the mitogen response of splenocytes was measured as follows: 10 mol indomethacin/L was added to the culture of splenocytes with conA (5 mg/L), which was incubated for 72 h at 37°C and then pulsed with 37 MBq (1.0 Ci) [ 3 H]thymidine. Twenty-four hours later, the splenocytes were harvested and their radioactivity was measured by using a liquid scintillation spectrometer.
Glucose uptake by splenocytes
Splenocytes (1 ϫ 10 8 cells/L) were cultured with conA (5 mg/L) for 48 h. Then the culture supernate was collected and used for the measurement of glucose as described above. Glucose uptake by splenocytes after in vitro incubation with conA for 48 h was calculated by comparing the glucose concentration in the culture supernate of splenocytes from lean or obese Zucker rats with that of glucose in the supernate without splenocytes.
Western immunoblotting for GLUT-1 protein
Cellular protein from splenic lymphocytes was extracted by lysing the cells, which was done by culturing them with conA (5 mg/L) for 48 h in lysis buffer (phosphate-buffered saline containing 1% Triton X-100, 50 mg aprotinin/L, 10 mg leupeptin/L, and 1 mmol phenylmethylsulfonyl fluoride/L) and quick-freezing the supernate. The protein concentrations were assayed by using the DC Protein Assay Kit (Bio-Rad, Tokyo). Total protein (75 g) was electroblotted onto nitrocellulose paper after separation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis using a 10-20% gradient gel. The filters were allowed to incubate for 2 h at 4°C with a 1:1000 dilution of rabbit anti-rat GLUT-1 antibody purchased from East-Acrea Biologicals (Southbridge, MA). The immunoblot was subsequently incubated for 1 h with a 1:2500 dilution of horseradish peroxidase-linked donkey anti-rabbit immunoglobulin antibody (Amersham, Buckinghamshire, United Kingdom). Positive bands were visualized by using the ECL detection system from Amersham. Expression of GLUT-1 in splenic lymphocytes was quantitated by using a laser densitometer (Ultrascan XL; Pharmacia LKB, Uppsala, Sweden).
Expression of conA receptors on splenic lymphocytes
Splenic lymphocytes were isolated from splenocytes by Percoll gradient centrifugation as reported previously (14) . Isolated splenic lymphocytes (1 ϫ 10 9 cells/L) were cultured with fluorescein isothiocyanate-conjugated conA (5 mg/L; Vector Laboratories, Inc, Burlingame, CA) for 1 h at 37°C. Then they were washed twice with phosphate-buffered saline (pH 7.2) containing 0.1% sodium azide and 0.1% bovine serum albumin and fixed with 0.5% paraformaldehyde. Fluorescence intensity per 10 5 splenic lymphocytes was determined by using a flow cytometer (EPICS XL-MCL; Coulter Co, Tokyo).
Statistical analysis
Data are means ± SDs. The statistical significance of differences between lean and obese Zucker rats was analyzed by Stu-dent's t test. The data on proliferation of splenic lymphocytes with conA were analyzed by two-way analysis of variance (ANOVA; Statistical Analysis System, SAS Institute, Cary, NC). Post hoc comparisons were made with Tukey's test. Differences were considered significant at P < 0.05.
RESULTS
Body and spleen weights and number of splenocytes
Obese Zucker rats were hyperphagic compared with lean Zucker rats during the experiment, which resulted in significantly higher body weights ( Table 1) . The mean body weight of the obese Zucker rats at the end of experiment was about three times higher than that of the lean Zucker rats. On the contrary, there were no significant differences in spleen
Plasma glucose, insulin, and triacylglycerol concentrations
Plasma insulin and triacylglycerol concentrations in the obese Zucker rats were significantly higher than those of the lean Zucker rats. However, there was no significant difference in plasma glucose concentration between obese and lean Zucker rats (Table 1) .
Mitogen response and PGE 2 production in splenic lymphocytes
In this experiment, mitogenesis of splenic lymphocytes with conA (1-10 mg/L) was measured by using the incorporation of [ 3 H]thymidine. As shown in Figure 1 , mitogen responses of splenic lymphocytes from the obese Zucker rats were significantly lower at all concentrations of conA compared with those of the lean Zucker rats. However, there was little difference between the obese and lean Zucker rats in the optimum concentration of conA needed to induce maximum proliferation of splenic lymphocytes. Production of PGE 2 by conA-stimulated splenocytes was significantly lower in the obese than in the lean Zucker rats (Figure 2) . Furthermore, the addition of indomethacin (10 mol/L) to the cultures of splenic lymphocytes with conA (5 mg/L) had no effect on the decreased mitogen response in the obese Zucker rats (Figure 2 ).
Glucose uptake by splenocytes
Glucose uptake by splenocytes was measured after in vitro incubation with conA (5 mg/L) for 48 h. As shown in Figure 3 , glucose uptake by splenocytes from obese Zucker rats was significantly lower than that of splenocytes from lean Zucker rats (P < 0.05).
GLUT-1 expression in splenic lymphocytes
It is known that the main glucose transporter expressed in immune cells such as lymphocytes and macrophages is GLUT-1. In this experiment, the expression of GLUT-1 in splenic lymphocytes after in vitro incubation with conA (5 mg/L) for 48 h was measured by using Western blot analysis. As shown in Figure 4 , the expression of GLUT-1 in splenic lymphocytes of the obese Zucker rats was lower than that of the lean Zucker rats.
Expression of conA receptors in splenic lymphocytes
In this experiment, the expression of conA receptors in splenocytes isolated from lean or obese Zucker rats was measured by using fluorescein isothiocyanate-conjugated conA. As shown in Figure 5 , there were no significant differences in the expression of conA receptors on splenic lymphocytes from lean and obese Zucker rats.
DISCUSSION
Currently, it is generally accepted that obesity is linked to the occurrence of hyperlipidemia, diabetes mellitus, atherosclerosis, infections, and some types of cancer (15) . Some of these diseases appear to be associated with the decrease in cellular immunity in obese persons. Although there are several reports showing that obesity induces the decrease of cellular immunity (4, 16) , the mechanism remains to be elucidated. Zucker rats were used in this study as a model for obesity. Although plasma insulin and triacylglycerol concentrations were much higher in the obese Zucker rats than in the lean Zucker rats (465% for insulin and 1151% for triacylglycerol), plasma glucose concentration was not different. Despite hyperinsulinemia and hyperlipidemia, obese Zucker rats do not have diabetes mellitus. Because diabetes mellitus has a major effect on the immune system (17) , Zucker rats are a suitable model to investigate the effect of obesity on cellular immunity.
As shown in Figure 1 , proliferation of splenic lymphocytes with conA was significantly lower in the obese than in the lean Zucker rats. Because the optimum concentration to induce maximum proliferation of splenic lymphocytes was not very different between the lean and obese Zucker rats, the decreased proliferation of splenic lymphocytes from obese Zucker rats appears to be due to lower responsiveness rather than to insufficient stimulation with conA. Because there are some reports showing that the quality and quantity of dietary lipids modulate cellular immunity (18, 19) and that an increased plasma insulin concentration is associated with a decrease in cellular immune functions such as natural killer cell activity and proliferation of peripheral blood lymphocytes (20, 21) , the lower responsiveness of splenic lymphocytes from obese Zucker rats may be, in part, related to the increased insulin and triacylglycerol concentrations in plasma.
Because the decrease in cellular immunity after a high-fat or high-polyunsaturated-fatty-acid diet is associated with increased production of PGE 2 (22) , the decreased lymphocyte proliferation in obese Zucker rats may be due to the increased production of PGE 2 . PGE 2 is produced in large amounts by macrophages and lymphocytes from aged people or animals (23, 24) and obese subjects (25) . In the obese Zucker rats the increased production of PGE 2 might have been induced, which resulted in decreased proliferation of splenic lymphocytes with conA. However, our results in this study did not support this hypothesis. PGE 2 production by splenocytes was significantly lower in the obese rats than in the lean Zucker rats (Figure 2 ). This result agrees with the finding of Gaskins et al (26) , who reported that cultures of adipocytes from obese Zucker rats had lower PGE 2 release rates than cultures from lean rats. As its mechanism, one possibility is that the decreased production of PGE 2 in obese Zucker rats may be associated with expression of a mutant gene expressed during fetal development that alters other subsequently expressed genes involved in PGE 2 biosynthesis. Another possibility is that the product of the mutant gene is involved in either membrane phospholipid synthesis or enzymatic synthesis of prostaglandins from membrane phospholipids. In addition, in vitro culture with indomethacin-an inhibitor of cyclooxygenase, which is a key enzyme in PGE 2 synthetic pathway-did not improve decreased proliferation of splenic lymphocytes in the obese Zucker rats. These findings suggest that PGE 2 is not associated with the decreased proliferation of splenic lymphocytes in obese Zucker rats.
The protein encoded by the obese (ob) gene, leptin, is being watched with keen interest. Leptin has the ability to induce proliferation, differentiation, and functional activation of hematopoietic cells (27) . Because plasma leptin concentrations are elevated in obese Zucker rats (28) , it is anticipated that their lymphocyte proliferation will be elevated. This conflicts with our finding in this study. However, because obese Zucker rats stop production of the mRNA that encodes the longer form of the leptin receptor, which is only capable of signaling proliferation or differentiation when expressed in hematopoietic cells (29) , this missense mutation in leptin receptor may explain, in part, the decreased proliferation of splenic lymphocytes in obese Zucker rats.
Obese Zucker rats have elevated plasma insulin and corticosterone concentrations relative to their lean littermates (30) . Because corticosterone depresses immune functions (31) , the increased corticosterone concentration in obese Zucker rats may also be associated with decreased cellular immunity.
We reported previously that the main energy source for mature lymphocytes is glucose, especially at the stage of proliferation after in vitro stimulation with mitogens (11) . On the basis of this report, we postulated that the decreased lymphocyte pro-FIGURE 2. Production of prostaglandin E 2 (PGE 2 ) by splenocytes and effect of indomethacin (10 mol/L) on proliferation of splenic lymphocytes in lean and obese Zucker rats. x -± SD; n = 10. *Significantly different from lean Zucker rats, P < 0.05.
FIGURE 3.
Glucose consumption by splenic lymphocytes from lean and obese Zucker rats. Glucose uptake was calculated by subtracting the glucose content in the medium after in vitro incubation with concanavalin A for 48 h from the glucose content in preculture medium. x -± SD; n = 10. *Significantly different from lean Zucker rats, P < 0.05. liferation in obese Zucker rats may have been due to the impairment of glucose uptake by lymphocytes. Muscle glucose uptake is lower in obese than in lean Zucker rats, which is involved in reduced plasma membrane GLUT-4 protein content and a defect in the insulin-stimulated activation of GLUT-4 (32, 33). However, there are no reports on glucose uptake of lymphocytes in obese Zucker rats. We found that glucose uptake by splenic lymphocytes was significantly lower in obese than in lean Zucker rats. This suggests that obese Zucker rats have an impaired glucose transport system in their splenic lymphocytes. Although several glucose transporters have been found in various tissues, GLUT-4, a major glucose transporter, is expressed in muscle and fat tissues and is closely associated with diabetes mellitus (34) . In immune cells, GLUT-1, but not GLUT-4, is expressed on the membranes after mitogen stimulation (35), which is not dependent on insulin stimulation (36) . Expression of GLUT-1 was remarkably depressed in splenic lymphocytes of the obese compared with the lean Zucker rats in the present study. This suggests that decreased proliferation of splenic lymphocytes in obese Zucker rats is associated with the impairment of glucose uptake, which is due to the decreased expression of GLUT-1. Because GLUT-1 expression is decreased in diabetes induced by streptozotocin (37) or alloxan (38) , hyperinsulinemia may down-regulate the expression of GLUT-1. GLUT-1 expression depends on mitogen stimulation and signal transduction after mitogen stimulation. If the number of mitogen receptors is lower on cells from obese Zucker rats, it might result in the decreased expression of GLUT-1 on splenic lymphocyte membranes. However, there was no significant difference in the expression of mitogen receptors on splenic lymphocytes between the lean and obese Zucker rats ( Figure 5) . Thus, the decreased expression of GLUT-1 in splenic lymphocytes of obese Zucker rats is not associated with the number of mitogen receptors. GLUT-1 is highly synthesized by the activation of mitogen-activated protein kinase after mitogen stimulation or the stimulation of the mitogen-activated protein kinase cascade via protein kinase C activation by phorbol myristate acetate (39) . Because glucose transport in heart muscle cells was depressed in obese Zucker rats, as was protein kinase C activity (40) , decreased expression of GLUT-1 in splenic lymphocytes of obese Zucker rats may be associated with the impairment of signal transduction after mitogen stimulation.
In our previous study we found that obesity is a risk factor for deteriorating cellular immune functions with aging. In that study, the decreased cellular immunity in aged people (> 60 y old) may have been due not only to the decreased responsiveness of immune cells but also to the decreased uptake of glucose through decreased expression of GLUT-1. In conclusion, this study gives experimental support for the hypothesis that the decreased cellular immunity, especially lymphocyte mitogenesis, in obese subjects is associated with the decreased uptake of glucose into immune cells, which is associated with the decreased expression of GLUT-1. 
